Cargando…

STAT5b in LGL leukemia – a novel therapeutic target?

Detalles Bibliográficos
Autores principales:	Rajala, Hanna L. M., Mustjoki, Satu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2013
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757236/ https://www.ncbi.nlm.nih.gov/pubmed/23868875

Ejemplares similares

A guilt-by-association mutation network in LGL leukemia
por: Andersson, Emma I., et al.
Publicado: (2017)

Emergence of a STAT3 mutated NK clone in LGL leukemia
por: Yan, Yiyi, et al.
Publicado: (2014)

STAT3 mutation impacts biological and clinical features of T-LGL leukemia
por: Teramo, Antonella, et al.
Publicado: (2017)

STAT3 activation in large granular lymphocyte leukemia is associated with cytokine signaling and DNA hypermethylation
por: Kim, Daehong, et al.
Publicado: (2021)

STAT5B(N642H) drives transformation of NKT cells: a novel mouse model for CD56(+) T-LGL leukemia
por: Klein, Klara, et al.
Publicado: (2019)

Immune control in chronic myeloid leukemia
por: Ilander, Mette, et al.
Publicado: (2017)

A case of LGL leukemia with paucity of erythropoiesis
por: Razavi, Habib M.
Publicado: (2020)

Cyclophosphamide as a first-line therapy in LGL leukemia
por: Moignet, A, et al.
Publicado: (2014)

STAT3 and STAT5B Mutations in T/NK-Cell Chronic Lymphoproliferative Disorders of Large Granular Lymphocytes (LGL): Association with Disease Features
por: Muñoz-García, Noemí, et al.
Publicado: (2020)

Retrovirus insertion site analysis of LGL leukemia patient genomes
por: Li, Weiling, et al.
Publicado: (2019)

Twins with different personalities: STAT5B—but not STAT5A—has a key role in BCR/ABL-induced leukemia
por: Kollmann, Sebastian, et al.
Publicado: (2019)

penner/lgl2 is required for the integrity of the photoreceptor layer in the zebrafish retina
por: Kujawski, Satu, et al.
Publicado: (2019)

Novel somatic mutations in large granular lymphocytic leukemia affecting the STAT-pathway and T-cell activation
por: Andersson, E I, et al.
Publicado: (2013)

Targeting the STAT5 pathway in Ph+ acute lymphoblastic leukemia
por: Minieri, Valentina, et al.
Publicado: (2018)

Are T-LGL Leukemia and NK-Chronic Lymphoproliferative Disorder Really Two Distinct Diseases?
por: Zambello, Renato, et al.
Publicado: (2014)

Cyclophosphamide induces durable molecular and clinical responses in patients with relapsed T-LGL leukemia
por: Braunstein, Zachary, et al.
Publicado: (2022)

Inhibition of glioblastoma malignancy by Lgl1
por: Gont, Alexander, et al.
Publicado: (2014)

Identification of novel STAT5B mutations and characterization of TCRβ signatures in CD4+ T-cell large granular lymphocyte leukemia
por: Bhattacharya, Dipabarna, et al.
Publicado: (2022)

Targeting STAT3 and STAT5 in Cancer
por: de Araujo, Elvin D., et al.
Publicado: (2020)

A novel class of somatic mutations in blood detected preferentially in CD8 + cells
por: Valori, Miko, et al.
Publicado: (2017)

BLNK mutation associated with T-cell LGL leukemia and autoimmune diseases: Case report in hematology
por: Fouquet, Guillemette, et al.
Publicado: (2022)

Case Report: mRNA vaccination-mediated STAT3 overactivation with agranulocytosis and clonal T-LGL expansion
por: Hirsiger, Julia R., et al.
Publicado: (2023)

A case report of T-LGL leukemia-associated pure red cell aplasia harboring STAT3, TNFAIP3, and KMT2D mutation
por: Shen, Meixiao
Publicado: (2023)

Drug sensitivity profiling identifies potential therapies for lymphoproliferative disorders with overactive JAK/STAT3 signaling
por: Kuusanmäki, Heikki, et al.
Publicado: (2017)

T-cell large granular lymphocytic (LGL) leukemia consists of CD4(+)/CD8(dim) and CD4(-)/CD8(+) LGL populations in association with immune thrombocytopenia, autoimmune neutropenia, and monoclonal B-cell lymphocytosis
por: Kuwahara, Naoya, et al.
Publicado: (2019)

Targeting the bone marrow microenvironment: a novel therapeutic strategy for pre-B acute lymphoblastic leukemia
por: Kotecha, Rishi S., et al.
Publicado: (2019)

dbLGL: an online leukemia gene and literature database for the retrospective comparison of adult and childhood leukemia genetics with literature evidence
por: Liu, Yining, et al.
Publicado: (2018)

Somatic STAT3 mutations in CD8(+) T cells of healthy blood donors carrying human T-cell leukemia virus type 2
por: Kim, Daehong, et al.
Publicado: (2021)

Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target
por: Dufva, Olli, et al.
Publicado: (2018)

Involvement of Lgl and Mahjong/VprBP in Cell Competition
por: Tamori, Yoichiro, et al.
Publicado: (2010)

Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia
por: Mosakhani, Neda, et al.
Publicado: (2013)

Successful treatment of cerebral aspergillosis: case report of a patient with T-cell large granular lymphocytic leukemia (T-LGL)
por: Turki, Amin T., et al.
Publicado: (2017)

CCR7 as a novel therapeutic target in t-cell PROLYMPHOCYTIC leukemia
por: Cuesta-Mateos, Carlos, et al.
Publicado: (2020)

IFNα induces prolonged remissions modeling curative immunologic responses in chronic myeloid leukemia
por: Ilander, Mette, et al.
Publicado: (2014)

LGL leukemia patients exhibit substantial protective humoral responses following SARS‐CoV‐2 vaccination
por: Cheon, Heejin, et al.
Publicado: (2022)

Therapeutic Targets in Chronic Lymphocytic Leukemia
por: Laurenti, Luca, et al.
Publicado: (2020)

A conserved polybasic domain mediates plasma membrane targeting of Lgl and its regulation by hypoxia
por: Dong, Wei, et al.
Publicado: (2015)

Toward a Better Classification System for NK-LGL Disorders
por: Drillet, Gaëlle, et al.
Publicado: (2022)

STAT5A and STAT5B—Twins with Different Personalities in Hematopoiesis and Leukemia
por: Maurer, Barbara, et al.
Publicado: (2019)

Lgl1 Is Required for Olfaction and Development of Olfactory Bulb in Mice
por: Li, Zhenzu, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fp2hdkvhbludr2esl73e09cjmi